Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Turcot syndrome × Radiation Dose Hypofractionation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Turcot syndrome 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Locally Advanced Cervical Carcinoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

pembrolizumab 3 Nivolumab 2 sintilimab 1 regorafenib 1 denileukin diftitox 1 Radiation Dose Hypofractionation 1 Ipilimumab 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 E7777 fusion protein 1 Clinical Trials, Phase II as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04636008 2024-08-06

Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer

West China Hospital

Phase 1/2 Recruiting

Gastrointestinal

Turcot syndrome, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡